With the departure of 13 veteran portfolio managers from
Brian Demain, for instance, is now running the $2.1 billion Janus Enterprise Fund, John Eisinger is now overseeing the $4.6 billion Janus Orion Fund, Andy Acker is overseeing the $870 million Janus Global Life Sciences Fund, and Brian Schaub and Chad Meade are jointly running the $131 million Janus Triton Fund.
The high turnover has made some investors nervous and raised questions about morale.
News last week that David Corkins will be leaving by the end of the year, coupled with the announcement in August that Scott Schoelzel also will be leaving by the end of the year is a “big blow to Janus,” according to